British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

U.S. Attorney General Pam Bondi said in a post on the social media platform X that charges against Dr. Michael Kirk Moore, of ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for ...

By having multiple epitopes in one molecule, MEFA vaccines can simultaneously target several features of the disease-causing ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

The team from Tel Aviv University developed a vaccine to combat the bacterium that causes the black plague, using the same ...

An ongoing Phase III clinical trial of DengiAll, a one-shot dengue vaccine developed by Panacea Biotec, is progressing in ...

Where a woman claimed she suffered a nerve injury after receiving two vaccine injections, but CVS was immune for its ...

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...

Vaccinations helped reduce cholera cases and deaths by 28 per cent and 36 per cent, respectively, across 40 cholera outbreaks between 2011 and 2023. For meningitis, cases and deaths fell by 27 per ...